Ocugen (OCGN) Operating Expenses (2014 - 2026)
Ocugen (OCGN) reported Operating Expenses of $19.4 million for Q1 2026, up 21.21% on a YoY basis from $16.0 million in Q1 2025, and up 15.3% quarter-over-quarter from $16.8 million in Q4 2025.
Ocugen (OCGN) Operating Expenses (2014 - 2026) Analysis & Trends
Ocugen has reported Operating Expenses for 13 years, with the latest figure at $19.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 21.21% year-over-year to $19.4 million; the trailing twelve-month figure through Mar 2026 stood at $70.7 million (up 14.87% YoY), and the FY2025 full-year result was $67.3 million, up 14.48% from the prior year.
- Operating Expenses for Q1 2026 stood at $19.4 million, up from $16.8 million in the prior quarter.
- The five-year high for Operating Expenses was $25.6 million in Q3 2022, with the low at $12.9 million in Q4 2023.
- Historically, Operating Expenses has averaged $18.2 million across 5 years, with a median of $16.8 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 176.75% — and 2023, when it slumped 46.63%.
- Ocugen's Operating Expenses stood at $24.2 million in 2022, then tumbled by 46.63% to $12.9 million in 2023, then climbed by 12.91% to $14.6 million in 2024, then advanced by 15.05% to $16.8 million in 2025, then advanced by 15.3% to $19.4 million in 2026.
- The last three Operating Expenses figures came in at $19.4 million (Q1 2026), $16.8 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 19.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.37 Mn |
| Dec 31, 2025 | 16.80 Mn |
| Sep 30, 2025 | 19.38 Mn |
| Jun 30, 2025 | 15.17 Mn |
| Mar 31, 2025 | 15.98 Mn |
| Dec 31, 2024 | 14.60 Mn |
| Sep 30, 2024 | 14.39 Mn |
| Jun 30, 2024 | 16.59 Mn |
| Mar 31, 2024 | 13.23 Mn |
| Dec 31, 2023 | 12.93 Mn |
| Sep 30, 2023 | 16.13 Mn |
| Jun 30, 2023 | 24.03 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 24.23 Mn |
| Sep 30, 2022 | 25.58 Mn |
| Jun 30, 2022 | 22.22 Mn |
| Mar 31, 2022 | 19.53 Mn |
| Dec 31, 2021 | 14.57 Mn |
| Sep 30, 2021 | 10.79 Mn |
| Jun 30, 2021 | 25.61 Mn |